Lipopolysaccharide inhibits the channel activity of the P2X7 receptor. - Wikidata - awgldk - TriplyDB

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

http://www.wikidata.org/entity/Q35214735

about

Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release.Action of natural products on p2 receptors: a reinvented era for drug discovery.

P2860

Q35581200-390E5FE0-2B44-4C12-B49A-A849951AA25F Q38057132-1A9E53AD-2B9C-4A91-8C00-DA9A83BB2C2A

P2860

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

http://www.wikidata.org/entity/Q35214735

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@ast

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@en

type

label

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@ast

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@en

prefLabel

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@ast

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@en

P1433

Q35214735-C263857E-2244-4193-9426-52D2042BC66D

P1476

Q35214735-5FD79595-60BB-43A9-A1B3-552043175D61

P2093

Q35214735-07A29750-B66C-4824-B7FA-B7D00C9C56A4

Q35214735-0DD015FF-1CD6-4D90-B909-82748599EE98

Q35214735-207A8A75-2FF1-48F3-8DA9-830EE1863DA2

Q35214735-3588191A-3EC6-4D1C-96EF-568D221AC873

Q35214735-584CB3AD-749E-45EB-9ECD-3DB523D54676

Q35214735-7918E078-8E21-4636-96F3-7BEC67076FC6

Q35214735-866DE73F-1ACB-43EB-AEAA-E2EBEC201B0A

Q35214735-8BDF9106-5CA1-4DDB-9860-8390019D5F99

Q35214735-98395983-2057-4050-9A79-CE823700ABE9

Q35214735-B3B83BE7-E82F-4FAF-AB2E-9DD3CE83450A

P2860

Q35214735-085A5680-3DFA-4F7F-B272-50F7CC7182B0

Q35214735-11A6DB68-4239-4EBD-963C-975CE8B7C1A3

Q35214735-13C5D10C-06FE-4A35-9403-E94054FBBAA8

Q35214735-143251ED-21D1-435C-9545-6C87E5804E43

Q35214735-196FA6F6-9E25-41BC-842D-D755B3DC97D3

Q35214735-238E096A-3C28-4FD4-9DF5-F7ACD06EC4F4

Q35214735-31AB845D-99C1-4C07-B21A-153C838BC310

Q35214735-372E3413-B5B1-41B8-BE11-A0C36D8CE5E5

Q35214735-389AD8C5-C17D-41BA-A2CF-23D10C3618F5

Q35214735-3A6ECF2F-0AEE-4137-AA71-A7B1234E4806

P304

Q35214735-3EC7DF40-E1E6-48D0-93F7-362C4783F2A9

P31

Q35214735-C0592AFA-FB58-445F-9AB0-640F617B14C5

P356

Q35214735-8D5CFBAE-2D80-4628-8BD1-CECC3F33148F

P478

Q35214735-2B3070F8-70FF-4BD8-B122-B498A1637BD9

P577

Q35214735-09689CC7-8023-4A2C-AD50-0B83FD694C2A

P5875

Q35214735-220FED34-FEA9-429D-B12F-B6181D719EDD

P698

Q35214735-EBC1EBE3-B47C-4226-B3A1-4339A6CF397A

P921

Q35214735-D2336ED1-1981-41B5-87B2-9185A6B3685A

P932

Q35214735-D4DCC496-4193-43BC-B055-7FCF95E2E2BF

P356

P1433

Mediators of Inflammation

P1476

Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

@en

P2093

Alejandro Escobar

http://www.w3.org/2001/XMLSchema#string

Antonello Penna

http://www.w3.org/2001/XMLSchema#string

Claudio Acuña-Castillo

http://www.w3.org/2001/XMLSchema#string

Claudio Coddou

http://www.w3.org/2001/XMLSchema#string

Elias Leiva-Salcedo

http://www.w3.org/2001/XMLSchema#string

Felipe E Rodríguez

http://www.w3.org/2001/XMLSchema#string

J Pablo Huidobro-Toro

http://www.w3.org/2001/XMLSchema#string

Jorge Escobar

http://www.w3.org/2001/XMLSchema#string

Margarita Montoya

http://www.w3.org/2001/XMLSchema#string

Miguel Rios

http://www.w3.org/2001/XMLSchema#string

P2860

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor

Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function

Molecular physiology of P2X receptors

P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release

Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway

Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

Signaling at purinergic P2X receptors

Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors

Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes

P304

152625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/152625

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51664859

http://www.w3.org/2001/XMLSchema#string

P698

21941410

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

3173735

http://www.w3.org/2001/XMLSchema#string